Literature DB >> 19665324

(18)F-FDG PET-CT simulation for non-small-cell lung cancer: effect in patients already staged by PET-CT.

Gerard G Hanna1, Jonathan McAleese, Kathryn J Carson, David P Stewart, Vivian P Cosgrove, Ruth L Eakin, Ashraf Zatari, Tom Lynch, Peter H Jarritt, V A Linda Young, Joe M O'Sullivan, Alan R Hounsell.   

Abstract

PURPOSE: Positron emission tomography (PET), in addition to computed tomography (CT), has an effect in target volume definition for radical radiotherapy (RT) for non-small-cell lung cancer (NSCLC). In previously PET-CT staged patients with NSCLC, we assessed the effect of using an additional planning PET-CT scan for gross tumor volume (GTV) definition. METHODS AND MATERIALS: A total of 28 patients with Stage IA-IIIB NSCLC were enrolled. All patients had undergone staging PET-CT to ensure suitability for radical RT. Of the 28 patients, 14 received induction chemotherapy. In place of a RT planning CT scan, patients underwent scanning on a PET-CT scanner. In a virtual planning study, four oncologists independently delineated the GTV on the CT scan alone and then on the PET-CT scan. Intraobserver and interobserver variability were assessed using the concordance index (CI), and the results were compared using the Wilcoxon signed ranks test.
RESULTS: PET-CT improved the CI between observers when defining the GTV using the PET-CT images compared with using CT alone for matched cases (median CI, 0.57 for CT and 0.64 for PET-CT, p = .032). The median of the mean percentage of volume change from GTV(CT) to GTV(FUSED) was -5.21% for the induction chemotherapy group and 18.88% for the RT-alone group. Using the Mann-Whitney U test, this was significantly different (p = .001).
CONCLUSION: PET-CT RT planning scan, in addition to a staging PET-CT scan, reduces interobserver variability in GTV definition for NSCLC. The GTV size with PET-CT compared with CT in the RT-alone group increased and was reduced in the induction chemotherapy group.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19665324     DOI: 10.1016/j.ijrobp.2009.04.045

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  17 in total

1.  Conventional 3D staging PET/CT in CT simulation for lung cancer: impact of rigid and deformable target volume alignments for radiotherapy treatment planning.

Authors:  G G Hanna; J R Van Sörnsen De Koste; K J Carson; J M O'Sullivan; A R Hounsell; S Senan
Journal:  Br J Radiol       Date:  2011-01-11       Impact factor: 3.039

2.  Interobserver delineation variation in lung tumour stereotactic body radiotherapy.

Authors:  G F Persson; D E Nygaard; C Hollensen; P Munck af Rosenschöld; L S Mouritsen; A K Due; A K Berthelsen; J Nyman; E Markova; A P Roed; H Roed; S Korreman; L Specht
Journal:  Br J Radiol       Date:  2012-09       Impact factor: 3.039

Review 3.  Challenges in the target volume definition of lung cancer radiotherapy.

Authors:  Susan Mercieca; José S A Belderbos; Marcel van Herk
Journal:  Transl Lung Cancer Res       Date:  2021-04

4.  The application of PET-CT to post-mastectomy regional radiation therapy using a deformable image registration.

Authors:  Yu Sun Lee; Kyoung Ju Kim; Seung Do Ahn; Eun Kyung Choi; Jong Hoon Kim; Sang-Wook Lee; Si Yeol Song; Sang Min Yoon; Young Seok Kim; Jin-Hong Park; Byung Chul Cho; Su Ssan Kim
Journal:  Radiat Oncol       Date:  2013-04-29       Impact factor: 3.481

5.  Radiotherapy Planning and Molecular Imaging in Lung Cancer.

Authors:  Angelina Filice; Massimiliano Casali; Patrizia Ciammella; Marco Galaverni; Federica Fioroni; Cinzia Iotti; Annibale Versari
Journal:  Curr Radiopharm       Date:  2020

6.  The use of PET/CT in radiotherapy planning: contribution of deformable registration.

Authors:  Ela Delikgoz Soykut; Esat Mahmut Ozsahin; Yildiz Yukselen Guney; Suheyla Aytac Arslan; Ozlem Derinalp Or; Muzaffer Bedri Altundag; Gamze Ugurluer; Pelagia G Tsoutsou
Journal:  Front Oncol       Date:  2013-04-12       Impact factor: 6.244

7.  Challenges and opportunities in patient-specific, motion-managed and PET/CT-guided radiation therapy of lung cancer: review and perspective.

Authors:  Stephen R Bowen; Matthew J Nyflot; Michael Gensheimer; Kristi R G Hendrickson; Paul E Kinahan; George A Sandison; Shilpen A Patel
Journal:  Clin Transl Med       Date:  2012-08-31

8.  The mediastinal staging accuracy of 18F-Fluorodeoxyglycose positron emission tomography/computed tomography in non-small cell lung cancer with variable time intervals to surgery.

Authors:  Karen Booth; Gerard G Hanna; Niall McGonigle; Kieran G McManus; James McGuigan; Joe O'Sullivan; Tom Lynch; Jonathan McAleese
Journal:  Ulster Med J       Date:  2013-05

9.  The clinical application of 4D 18F-FDG PET/CT on gross tumor volume delineation for radiotherapy planning in esophageal squamous cell cancer.

Authors:  Yao-Ching Wang; Te-Chun Hsieh; Chun-Yen Yu; Kuo-Yang Yen; Shang-Wen Chen; Shih-Neng Yang; Chun-Ru Chien; Shih-Ming Hsu; Tinsu Pan; Chia-Hung Kao; Ji-An Liang
Journal:  J Radiat Res       Date:  2012-06-05       Impact factor: 2.724

10.  Current concepts in F18 FDG PET/CT-based radiation therapy planning for lung cancer.

Authors:  Percy Lee; Patrick Kupelian; Johannes Czernin; Partha Ghosh
Journal:  Front Oncol       Date:  2012-07-11       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.